Dr. Carlo Gambacorti-Passerini, a prominent CML researcher from the University of Milan Bicocca, gives us an update on bosutinib, a newer Tyrosine Kinase Inhibitor (TKI) that he has studied in-depth.
?
Watch now>
- Alternative Medicine Bone and Joint Disorders Cancer Children's Health Chronic Pain
- Clinical Trials Digestive Disorders Endocrine Issues Genetic Disorders Geriatric Care Healthcare Issues Heart Problems
- Infectious disease Medical Breakthroughs Men's Health Mental Health Neurological Conditions Nutrition
- Oral Health Reproductive Health Respiratory Conditions Skin Conditions Surgery
- Vision and Hearing Women's Health
Patient Power® connects you with the latest news and the most authoritative experts – patients as well as doctors – for your health concern. learn more >
State-of-the-Art Knee Replacement
Listen to Program >>
Featured Partner
National Comprehensive Cancer Network (NCCN)
National Comprehensive Cancer Network (NCCN)
Home :
Search :
Health Topics :
Program Guide :
Medical Experts :
News :
Community
About : Contact : Editorial Independence : Privacy Policy : Terms of Use
©2005 - 2010 Patient Power, LLC : Site by SiteWeld
About : Contact : Editorial Independence : Privacy Policy : Terms of Use
©2005 - 2010 Patient Power, LLC : Site by SiteWeld
Questions? Comments? Record now at: 877.232.5445
 | We comply with the HONcode standard for trustworthy health information: verify here. |
